179 related articles for article (PubMed ID: 16311023)
21. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
[TBL] [Abstract][Full Text] [Related]
22. [Hyper-IgM syndrome in members of two unrelated Chilean families: molecular and mutation analysis].
Luttges PD; Retamal DF; Spencer MY; Carrión FA; Valenzuela VM; Navarro SV; De Cornejo ML
Rev Med Chil; 2004 Oct; 132(10):1179-88. PubMed ID: 15631205
[TBL] [Abstract][Full Text] [Related]
23. The hyper IgM syndrome--an evolving story.
Etzioni A; Ochs HD
Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
[TBL] [Abstract][Full Text] [Related]
24. Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis.
Villa A; Notarangelo LD; Di Santo JP; Macchi PP; Strina D; Frattini A; Lucchini F; Patrosso CM; Giliani S; Mantuano E
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2110-4. PubMed ID: 7907793
[TBL] [Abstract][Full Text] [Related]
25. Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome.
López-Granados E; Cambronero R; Ferreira A; Fontán G; García-Rodríguez MC
Clin Exp Immunol; 2003 Jul; 133(1):123-31. PubMed ID: 12823286
[TBL] [Abstract][Full Text] [Related]
26. CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
[TBL] [Abstract][Full Text] [Related]
27. Mutations of CD40 ligand in two patients with hyper-IgM syndrome.
García-Pérez MA; Paz-Artal E; Corell A; Moreno A; López-Goyanes A; García-Martín F; Vázquez R; Pacho A; Romo E; Allende LM
Immunobiology; 2003; 207(4):285-94. PubMed ID: 12952351
[TBL] [Abstract][Full Text] [Related]
28. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
[TBL] [Abstract][Full Text] [Related]
29. Intrinsic defect in B cells of patients with hyper-immunoglobulin M syndrome.
Porat YB; Levy D; Levy J; Zan-Bar I
Clin Diagn Lab Immunol; 1995 Jul; 2(4):412-6. PubMed ID: 7583916
[TBL] [Abstract][Full Text] [Related]
30. CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand.
Seyama K; Osborne WR; Ochs HD
J Biol Chem; 1999 Apr; 274(16):11310-20. PubMed ID: 10196221
[TBL] [Abstract][Full Text] [Related]
31. Hyper-IgM syndrome: report of one case.
Ma YC; Shyur SD; Huang LH; Wu JY; Lin SC
Acta Paediatr Taiwan; 2004; 45(6):334-9. PubMed ID: 15868849
[TBL] [Abstract][Full Text] [Related]
32. X-linked hyper IgM (HIGM1) in an African kindred: the first report from South Africa.
Pienaar S; Eley BS; Hughes J; Henderson HE
BMC Pediatr; 2003 Nov; 3():12. PubMed ID: 14641931
[TBL] [Abstract][Full Text] [Related]
33. Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency.
Tahara M; Pergolizzi RG; Kobayashi H; Krause A; Luettich K; Lesser ML; Crystal RG
Nat Med; 2004 Aug; 10(8):835-41. PubMed ID: 15273748
[TBL] [Abstract][Full Text] [Related]
34. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
[TBL] [Abstract][Full Text] [Related]
35. Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L.
Bonnefoy JY; Gauchat JF; Life P; Graber P; Mazzei G; Aubry JP
Eur Respir J Suppl; 1996 Aug; 22():63s-66s. PubMed ID: 8871046
[TBL] [Abstract][Full Text] [Related]
36. Recurrent acalculous cholecystitis and sclerosing cholangitis in a patient with X-linked hyper-immunoglobulin M syndrome.
Lin SC; Shyur SD; Ma YC; Huang LH; Lee HC; Lee WI
J Formos Med Assoc; 2005 Jun; 104(6):421-6. PubMed ID: 16037832
[TBL] [Abstract][Full Text] [Related]
37. Long-term study of a female hyper-IgM immunodeficiency.
Kaneko H; Fukao T; Inoue R; Kasahara K; Matsui E; Kondo N
Exp Clin Immunogenet; 2000; 17(4):173-8. PubMed ID: 11096255
[TBL] [Abstract][Full Text] [Related]
38. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
[TBL] [Abstract][Full Text] [Related]
39. [X-linked hyper-IGM syndrome associated to sclerosing cholangitis and gallbladder neoplasm: clinical case].
Rodríguez C; Carrión F; Marinovic MA; Chávez E; Preisler J; Pooley F; Futatani T; Ochs HD
Rev Med Chil; 2003 Mar; 131(3):303-8. PubMed ID: 12790080
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome.
Zhu X; Chung I; O'Gorman MR; Scholl PR
Clin Immunol; 2001 Jun; 99(3):334-9. PubMed ID: 11358428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
